Bariatric surgery post-Liver Transplantation: A Belgian nationwide study.
Louis OnghenaAnja GeertsFrederik BerrevoetJacques PirenneJef VerbeekEliano Bonaccorsi-RianiGeraldine DahlqvistLuisa VonghiaOlivier DetryJean DelwaideSander LefereYves van NieuwenhovePublished in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)
SG is the favored BS post-LT and has proven to be safe and feasible in a post-LT setting with favorable metabolic consequences. SG post-LT is a valid treatment for de novo and recurrent MASLD post-LT. Although we report on the largest cohort to date, there is still a need for larger cohorts to examine the effect of BS on patient and graft survival.
Keyphrases